ZYLOXTB trims outstanding H-shares by 0.05% in October; treasury stock climbs to 4.25% of share capital

Bulletin Express11-04

Zylox-Tonbridge Medical Technology Co., Ltd. (ZYLOXTB) released its Monthly Return for the period ended 31 October 2026, detailing a modest share repurchase and updated equity statistics.

Authorised capital remains unchanged • The company’s registered share capital held steady at 344.13 million ordinary shares—336.35 million H-shares and 7.78 million unlisted domestic shares—each with a par value of RMB 1.

Issued share movements • Outstanding H-shares (excluding treasury) declined by 0.05% to 322.06 million following the repurchase of 159,500 shares on 13 May 2026 that were transferred to treasury. • Total issued shares, including treasury, were unchanged at 336.35 million.

Rising treasury position • Treasury stock increased to 14.29 million H-shares, equivalent to 4.25% of the company’s total issued shares, up from 14.13 million a month earlier.

Public float intact • Management confirmed compliance with the Main Board’s minimum 25% public-float requirement for the H-share class.

Equity incentive capacity • The 2025 Share Incentive Scheme shows 400,000 outstanding options, while 17.42 million shares remain available for future grants. • Under the Share Award Scheme adopted on 19 December 2024, up to 611,939 shares may still be issued or transferred from treasury.

Domestic shares stable • The unlisted domestic share count was unchanged at 7.78 million.

No warrants, convertibles or other capital-raising instruments were reported during the month. Overall, October’s activity underscores Zylox-Tonbridge’s ongoing share repurchase strategy while maintaining regulatory float and incentive flexibility.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment